Status:
UNKNOWN
Evaluate the Diagnostic Value of Puncture Biopsy for PPL Under the Guidance of Navigation and Radial EBUS: a Real-World Study
Lead Sponsor:
Guangzhou Institute of Respiratory Disease
Conditions:
Lung; Nodes
Eligibility:
All Genders
18+ years
Brief Summary
The study is designed to evaluate the safety and effectiveness of biopsy forceps combined with puncture biopsy for the diagnosis of peripheral pulmonary nodules under the guidance of Augmented Reality...
Detailed Description
The study will last for no longer than 12 months. Patients will be first screened, and only after meeting all the inclusion criteria, not meeting any exclusion criteria, and signing the informed conse...
Eligibility Criteria
Inclusion
- 1\. Age ≥ 18 years old; 2. Chest CT shows that the peripheral lung noduleswith uncertain diagnosis are adjacent or far from the airway, and/or are difficult to obtain samples by routine biopsy as assessed by investigators; 3. Understand the research and sign the informed consent form.
Exclusion
- 1\. Contraindications for bronchoscopy; 2. Severe cardiopulmonary dysfunction and other diseases that may significantly increase the risk of surgery; 3. Bronchoscopy shows visible intra-airway nodules above the 3rd bronchus; 4. The investigator believes that the patient has other conditions that are not suitable for inclusion in this study.
Key Trial Info
Start Date :
January 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 20 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04692038
Start Date
January 10 2021
End Date
March 20 2022
Last Update
January 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China, 510120